NTT-ELECTRONICS
13.11.2019 07:02:08 CET | Business Wire | Press release
NTT Electronics, a leading provider of advanced components for optical communications systems including coherent optics and digital signal processors (DSPs), contributes the Goldstone Network Operating Software (NOS *1) for disaggregated coherent transponders to the Telecom Infra Project’s NOS Software Project hosted by the Open Optical and Packet Transport project group. Launched in February 2016, TIP was started with the goal of accelerating the pace of innovation in the telecom industry.
Goldstone utilizes many existing open source components which have been developed in Open Compute Project (OCP *2) and Telecom Infra Project (TIP *3) including Open Network Linux (ONL *4), SONiC *5, Switch Abstraction Interface (SAI *6) and Transponder Abstraction Interface (TAI *7) to provide a full-fledged open source solution. ONL is used as the base operating system and provides a wide range of open network device support. On top of ONL, Kubernetes *8 is employed to enable containerized application management, which realizes flexible and modular software composition. SONiC/SAI is deployed as a fleet of containers when the target hardware comprises Ethernet switch ASIC, whereas TAI is used when the target hardware has coherent transponder components. Because of its modular architecture, Goldstone can be extended to support networking devices, which don’t have Ethernet ASIC, but may include conventional transponders, ROADMs or amplifiers in the future.
Goldstone was originally started as a prototype NOS for Edgecore’s Cassini Platform by the proposal from NTT Electronics. This has led to a production deployment by mixi in Japan.
More than five industry partners are using Goldstone for evaluation on the Cassini platform.
It is also being incorporated in Wistron’s Galileo platform.
The NOS is planned to be contributed to TIP Open Optical Packet Transport (OOPT *9) group as an open source project. Goldstone is planned to be part of a live running demonstration at the TIP Summit 2019.
Quote from mixi, Inc.
“As the first operator who deployed Goldstone in production, mixi welcomes the contribution of Goldstone by NTT Electronics to foster more collaboration among the open networking industry. Goldstone brought us huge flexibility and control over our DCI connectivity which is critical for our services” Tatsuma Murase, CTO, mixi, Inc.
Quote from Edgecore
“Edgecore is pleased to be working with NTT Electronics and the broader industry community to enable disaggregated solutions with open packet transponders that will provide broader optical technology choices for network operators.” George Tchaparian, President and CEO, Edgecore Networks
Quote from Wistron
“Wistron is excited to have Goldstone in the open networking industry. Goldstone will accelerate the adaptation of the open disaggregated networking model and we believe it will become a viable solution together with our latest Galileo platform.” Arthur Chang, Sr. Technical Director, Wistron
*1 Network Operating System (NOS) : Operating system for a network device such as a router, switch or firewall.
*2 Open Compute Project (OCP) : The Open Compute Project (OCP) is a collaborative community focused on redesigning hardware technology to efficiently support the growing demands on compute infrastructure. In 2011, Facebook shared its designs with the public and launched the Open Compute Project and incorporated the Open Compute Project Foundation along with Intel, Rackspace, Goldman Sachs and Andy Bechtolsheim. (Reference: OCP web site: https://www.opencompute.org/ )
*3 Telecom Infra Project (TIP) : The Telecom Infra Project (TIP) is a collaborative telecom community founded by Facebook and partners. Launched in February 2016, TIP was started with the goal of accelerating the pace of innovation in the telecom industry. TIP members include operators, suppliers, developers, integrators, startups, and other entities that have joined TIP to build new technologies and develop innovative approaches for deploying telecom network infrastructure. (Reference: TIP web site: https://telecominfraproject.com/ )
*4 Open Network Linux (ONL) : Open Network Linux(ONL) is an open-source, foundational platform software layer for next-generation, modular NOS architecture on open networking hardware. ONL is a part of the Open Compute Project and is a component in a growing number of commercial NOS stacks and open source projects like CoRD & Stratum. (Reference: ONL web site : http://opennetlinux.org/ )
*5 Software for Open Networking in the Cloud (SONiC) : Open source software developed by Microsoft, etc.. It dramatically enhances operations and management of network switches. (Reference: SONiC repository: http://azure.github.io/SONiC/ )
*6 Switch Abstraction Interface (SAI) : The Switch Abstraction Interface (SAI) defines the API to provide a vendor-independent way of controlling forwarding elements, such as a switching ASIC, an NPU or a software switch in a uniform manner. (Reference: SAI repository: https://github.com/opencomputeproject/SAI )
*7 Transponder Abstraction Interface (TAI) : The Transponder Abstraction Interface (TAI) is the open API to provide a vendor-independent way of controlling coherent optical components. TAI has been developed under TIP OOPT group and NTT is leading the development. https://www.ntt.co.jp/news2018/1810e/181016c.html
*8 Kubernetes : Kubernetes is a portable, extensible, open-source platform for managing containerized workloads and services. Google open-sourced the Kubernetes in 2014. (Reference: Kubernetes web site : https://kubernetes.io/ )
*9 Open Optical Packet Transport (OOPT) : The Open Optical & Packet Transport project group will define Dense Wavelength Division Multiplexing (DWDM) open packet transport architecture that triggers new innovation and avoids implementation lock-ins. Open DWDM systems include open line system & control, transponder & network management and packet-switch and router technologies. (Reference: TIP web site: https://telecominfraproject.com/oopt/ )
About NTT Electronics
NTT Electronics (NEL) has been developing and commercializing optical communications devices since 1995. It has complete portfolio of optical and electronics products to cover the industry needs for 100G-and-beyond link systems, ROADM components and FTTH networks. For more information about NEL, visit https://www.ntt-electronics.com/en/ .
View source version on businesswire.com: https://www.businesswire.com/news/home/20191112006191/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom